Published online Jun 28, 2024. doi: 10.3748/wjg.v30.i24.3076
Revised: May 21, 2024
Accepted: May 31, 2024
Published online: June 28, 2024
Processing time: 95 Days and 9.2 Hours
Helicobacter pylori (H. pylori) infection is closely associated with gastrointestinal diseases. Our preliminary studies have indicated that H. pylori infection had a significant impact on the mucosal microbiome structure in patients with gastric ulcer (GU) or duodenal ulcer (DU).
To investigate the contributions of H. pylori infection and the mucosal microbiome to the pathogenesis and progression of ulcerative diseases.
Patients with H. pylori infection and either GU or DU, and healthy individuals without H. pylori infection were included. Gastric or duodenal mucosal samples was obtained and subjected to metagenomic sequencing. The compositions of the microbial communities and their metabolic functions in the mucosal tissues were analyzed.
Compared with that in the healthy individuals, the gastric mucosal microbiota in the H. pylori-positive patients with GU was dominated by H. pylori, with signi
H. pylori infection significantly alters the gastric microbiota structure, diversity, and biological functions, which may be important contributing factors for GU.
Core Tip: In this study, we explored the influence and mechanism of action of Helicobacter pylori (H. pylori) on the development of gastric ulcer and duodenal ulcer, which are currently inconclusive. Metagenomic sequencing was performed on mucosal samples from H. pylori-infected patients with gastric ulcer or duodenal ulcer and healthy individuals. Mucosal flora structure, differentially functional genes, and metabolic pathways were analyzed to explore the role that H. pylori plays in the development of gastric ulcer and duodenal ulcer. Ultimately, two key metabolic pathways and related genes contributed from H. pylori were identified.